Juvaris BioTherapeutics news from FierceBiotech
News
Emerging Drug Developer: Juvaris BioTherapeutics
Juvaris BioTherapeutics Kleiner Perkins was so impressed by the research work underway at... Read more...
Emerging Drug Developer: Juvaris BioTherapeutics
Juvaris ramps up its clinical vaccine programs When Kleiner Perkins Caufield & Byers set up its pandemic and biodefense fund, its lead partner on the initiative--Thomas Monath, M.D.--was... Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
